More than 43% of women between the ages of 18 and 59 have experienced some degree of sexual dysfunction, compared with only 31% of men. Yet, Female Sexual Dysfunction (FSD) as a disorder has been widely overlooked. That’s why BioSante Pharmaceuticals developed LibiGel®, a testosterone gel that hopes to bring relief to millions of women. To help bring attention to female sexual health, HDM developed an ongoing public relations program, a new website, updated logo, annual report, and a video presentation for the NASDAQ Tower in Times Square.
